Genfit S.A. GNFT
Set alert
As of Mar 9, 9:30 AM ET
- YTD
- +44.59%
- 1 year
- +157.93%
- Open
- 9.00
- Prev close
- 8.95
- Mkt cap
- 190.64M
- Vol
- 4.21K
- Avg vol
- 12.52K
- EPS
- 0.39
- P/E
- 9.79
- Div yield
- 0.00%
More statistics
- Low
- 8.85
- High
- 9.00
- Forward P/E
- 0.00
- Beta
- 1.12
- Short ratio
- 9.11
- Inst. own
- 0.26%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 4, 2024
- 50-d avg
- 4.87
- 200-d avg
- 4.36
- 1y target
- 10.13
News
1 month ago seekingalpha.com
Genfit S.A. (GNFTF) Discusses Developments and Guidance in MASH Diagnostics Transcript
Genfit S.A. (GNFTF) Discusses Developments and Guidance in MASH Diagnostics Transcript
4 months ago globenewswire.com
GENFIT: June 15, 2026 Combined Shareholders Meeting Results
All resolutions recommended by the Board of Directors approved (quorum: 32. 13 %) Lille (France); Cambridge, (Massachusetts, United States); Zurich (Switzerland); June 15, 2026 - GENFIT (Euronext:…
4 months ago globenewswire.com
GENFIT : Résultats de l’Assemblée Générale Mixte du 15 juin 2026
L'ensemble des projets de résolutions recommandés par le Conseil d'Administration a été approuvé (quorum: 32,13 %) Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 15 juin…
4 months ago globenewswire.com
GENFIT: NASHnext®, Powered by GENFIT's Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp's OnDemand Offering for Identification of At-Risk MASH
Labcorp OnDemand enables convenient testing with the NASHnext® test, within a physician-directed care pathway to support identification of patients with at-risk MASH This model expands access and…
5 months ago globenewswire.com
GENFIT Annual General Meeting of June 15, 2026 - Shareholders' letter
Dear Shareholders, We are pleased to send you, in the attached document, GENFIT's Shareholders' Letter published ahead of our Annual General Meeting to be held on June 15, 2026. This letter outlines…
5 months ago globenewswire.com
GENFIT Highlights Broad Scientific and Strategic Presence at EASL Congress 2026
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 25, 2026 – GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with…
5 months ago globenewswire.com
GENFIT Reports First Quarter 2026 Financial Information and Provides a Corporate Update
Lille (France); Cambridge, ( Massachusetts, United States); Zurich (Switzerland); May 21, 2026 - GENFIT (Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of…
5 months ago globenewswire.com
GENFIT Annual Combined General Meeting of June 15, 2026 — Availability of Preparatory Documents
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 11, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with…
5 months ago globenewswire.com
GENFIT : Assemblée Générale Mixte du 15 juin 2026 — modalités de mise à disposition des documents préparatoires
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 11 mai 2026 - GENFIT (Euronext: GNFT), société biopharmaceutique engagée dans l'amélioration de la vie des patients atteints…
6 months ago globenewswire.com
GENFIT: Publication of the 2026 Extra-Financial Report (fiscal year 2025)
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 20, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with…
7 months ago globenewswire.com
GENFIT Reports Full-Year 2025 Financial Results and Provides Corporate Update
Lille, France; Cambridge, MA; Zurich, Switzerland; April 2, 2026 - GENFIT (Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and…
7 months ago globenewswire.com
GENFIT Receives FDA Orphan Drug Designation for NTZ for the treatment of ACLF
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), March 9, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with…
8 months ago globenewswire.com
GENFIT to receive US$20M milestone after Ipsen's Iqirvo® exceeds the US$200M threshold in its first full year of net sales
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), February 12, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients…
9 months ago globenewswire.com
GENFIT Announces 2026 Financial Calendar
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 7, 2026 - GENFIT (Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of…
10 months ago globenewswire.com
GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), December 10, 2025 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients…
10 months ago globenewswire.com
GENFIT : GNS561 montre une activité antitumorale prometteuse en combinaison thérapeutique
Données préliminaires très encourageantes de l'étude de Phase 1b en cours évaluant le médicament expérimental GNS561 associé à un inhibiteur de MEK (MEKi) dans le cholangiocarcinome (CCA) avec…
11 months ago globenewswire.com
GENFIT Announces Appointment of new Chief Medical Officer
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 27, 2025 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients…
11 months ago globenewswire.com
GENFIT Reports Third Quarter 2025 Financial Information and Provides a Corporate Update
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 20, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of…
11 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
1 year ago benzinga.com
Globus Maritime, Firefly Aerospace And 3 Stocks To Watch Heading Into Monday
U.S. stock futures down, Firefly Aerospace, PRA Group, Genfit, Globus Maritime, & Marygold Companies in focus.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
1 year ago benzinga.com
Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket
Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket
-
2 years ago benzinga.com
Why Nike Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Why Nike Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
-
2 years ago benzinga.com
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Before 10 a.m. ET Thursday, 132 stocks made new 52-week lows.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 193 companies set new 52-week lows.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday
-
7 years ago benzinga.com
48 Stocks Moving In Monday's Mid-Day Session
48 Stocks Moving In Monday's Mid-Day Session